CHIR99021

Last updated
CHIR99021
CHIR99021 structure.png
Names
IUPAC name
6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile
Other names
Laduviglusib [1]
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
ECHA InfoCard 100.236.922 OOjs UI icon edit-ltr-progressive.svg
EC Number
  • 809-015-4
KEGG
PubChem CID
UNII
  • InChI=1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32)
    Key: AQGNHMOJWBZFQQ-UHFFFAOYSA-N
  • N#CC1=CN=C(NCCNC2=NC=C(C3=NC(C)=CN3)C(C4=CC=C(Cl)C=C4Cl)=N2)C=C1
Properties
C22H18Cl2N8
Molar mass 465.34 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

CHIR99021 is a chemical compound which acts as an inhibitor of the enzyme GSK-3. [2] It has proved useful for applications in molecular biology involving the transformation of one cell type to another. [3] [4]

A mixture of CHIR99021 and valproic acid (FX-322) is claimed to increase the proliferation of inner ear stem cells, potentially allowing regrowth of the hair cells which are important for hearing, and are lost through chronic exposure to loud noises or as part of the aging process. [5] [6] [7]

The substance has been used as part of a chemical cocktail to turn old and senescent human cells back into young ones (as measured by transcriptomic age), without turning them all the way back into undifferentiated stem cells. [8]

See also

References

  1. "Laduviglusib". PubChem. Retrieved 2025-03-20.
  2. An WF, Germain AR, Bishop JA, Nag PP, Metkar S, Ketterman J, et al. (16 April 2012). "Discovery of Potent and Highly Selective Inhibitors of GSK3b". Probe Reports from the NIH Molecular Libraries Program. Bethesda (MD): National Center for Biotechnology Information (US). PMID   23658955.
  3. Singh VK, Kumar N, Kalsan M, Saini A, Chandra R (2015). "Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs)". Journal of Stem Cells. 10 (1): 43–62. PMID   26665937.
  4. Takeda Y, Harada Y, Yoshikawa T, Dai P (June 2018). "Chemical compound-based direct reprogramming for future clinical applications". Bioscience Reports. 38 (3) BSR20171650. doi:10.1042/BSR20171650. PMC   5938430 . PMID   29739872.
  5. US 2017226477,Karp JM, Yin X, Succi MD, Langer RS,"Compositions and methods for epithelial stem cell expansion and culture",published 10 August 2017, assigned to Massachusetts Institute of Technologyand The Brigham and Women's Hospital, Inc.
  6. US 11033546,Loose C, McLean W, Harrison M, Jirousek MR,"Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor",published 15 June 2021, assigned to Frequency Therapeutics Inc.
  7. McLean WJ, Yin X, Lu L, Lenz DR, McLean D, Langer R, et al. (February 2017). "Clonal Expansion of Lgr5-Positive Cells from Mammalian Cochlea and High-Purity Generation of Sensory Hair Cells". Cell Reports. 18 (8): 1917–1929. doi:10.1016/j.celrep.2017.01.066. PMC   5395286 . PMID   28228258.
  8. Yang JH, Petty CA, Dixon-McDougall T, Lopez MV, Tyshkovskiy A, Maybury-Lewis S, Tian X, Ibrahim N, Chen Z, Griffin PT, Arnold M, Li J, Martinez OA, Behn A, Rogers-Hammond R, Angeli S, Gladyshev VN, Sinclair DA (July 2023). "Chemically induced reprogramming to reverse cellular aging". Aging. 15 (13): 5966–5989. doi:10.18632/aging.204896. PMC   10373966 . PMID   37437248.